Yeting Shi

Associate

Washington + 1.202.879.3656

Connect:

Share

Yeting Shi focuses her practice on complex antitrust and competition law issues across matters involving government investigation, merger review, and class action. Yeting has represented clients across several industries, including health care, agriculture, and manufacturing.

Yeting is a member of the Antitrust Section of the American Bar Association.

Experience

  • Vanderbilt University Medical Center acquires remaining 80% interest in Tennova Healthcare-ClarksvilleJones Day is advising Vanderbilt University Medical Center ("VUMC") in its acquisition of Community Health Systems, Inc.'s 80% interest in Tennova Healthcare-Clarksville and certain ancillary businesses located in Clarksville, Tennessee, for $600 million.
  • Pentair acquires Hydra-StopJones Day represented Pentair plc (NYSE: PNR), a global leader in water systems, in its acquisition of Hydra-Stop, a leading insertion valve and line stop manufacturer, from Madison Industries for approximately $290 million in cash.
  • Hexagon sells Design & Engineering business to CadenceJones Day is advising Hexagon AB in the €2.7 billion sale of its Design & Engineering business, which includes the business formerly known as MSC Software, to Cadence Design Systems.
  • Verint agrees to be acquired by Thoma Bravo for $2 billionJones Day is advising Verint Systems Inc. (NASDAQ: VRNT), a global leader in Customer Experience (CX) Automation software, in connection with a take private transaction entered into with Thoma Bravo, a leading private equity firm primarily investing in software and technology companies, to become a privately held company in an all-cash transaction reflecting an enterprise value of $2 billion.
    • View All

    June 2024 Alert

    Unraveling the Forced Labor Stitched Into the Textile Industry

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.